Oxymatrine Inhibits Mitophagy via PINK1/Parkin Pathway: Neuroprotective Effects in Cerebral Ischemia/Reperfusion Injury

This study investigates the neuroprotective potential of oxymatrine in mitigating cerebral ischemia/reperfusion injury. The central hypothesis posits that oxymatrine exerts its protective effects by inhibiting mitophagy, a cellular process for removing damaged mitochondria, through the PINK1/Parkin pathway. This inhibition, in turn, influences mitochondrial dynamics, the balance between mitochondrial fission and fusion, and helps maintain mitochondrial homeostasis, ensuring the optimal functioning of these crucial cellular powerhouses. Ultimately, by preserving mitochondrial health and function, oxymatrine is hypothesized to contribute to neuroprotection in the context of cerebral ischemia/reperfusion injury. This study aims to elucidate the intricate mechanisms by which oxymatrine modulates mitochondrial dynamics and provides neuroprotection during cerebral ischemia/reperfusion, potentially paving the way for novel therapeutic strategies for this devastating condition.